Effective on trade date Monday, May 3, 2021, and pending all relevant CFTC regulatory review periods, this Market Regulation Advisory supersedes CME Group Market Regulation Advisory Notice RA2101-5RR from March 15, 2021. It is being issued based on amendments to CME, CBOT, and NYMEX/COMEX Rule 559 (“Position Limits and Exemptions”) that harmonize the rule text with language already contained in RA2101-5RR and the CFTC’s final rules concerning position limits. Specifically, the amendments codify the requirements attendant to market participants who submit a position limit exemption application after exceeding a position limit.
Click HERE to view the full advisory.